Revenue from contracts with customers for the 6 month period of the Company increased from $25.315 million to $29.288 million, an increase of 15.7 per cent.
The company posted a 15.7 per cent increase in revenue from operations to $29.3 million.
Shares in Pro Medicus (ASX:PME) are trading 5 per cent higher at $28.67.